| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-PD-1 antibody (Tislelizumab) combined with gemcitabine and oxaliplatin for extranodal NK/T-cell lymphoma failing asparaginase: A multicenter phase II trial
|
Ding, Kaiyang
|
|
|
214 |
C |
p.
|
artikel
|
| 2 |
An updated review of immune checkpoint inhibitors in cutaneous oncology: Beyond melanoma
|
Pham, James P.
|
|
|
214 |
C |
p.
|
artikel
|
| 3 |
Cancer immunotherapy in elderly patients: The concept of immune senescence challenged by clinical experience
|
Guégan, Mathilde
|
|
|
214 |
C |
p.
|
artikel
|
| 4 |
Cutaneous relapses location in diffuse large B-cell lymphoma leg type after first line immunochemotherapy
|
Benarfa, A.
|
|
|
214 |
C |
p.
|
artikel
|
| 5 |
Defying the odds: Outstanding survival in lung-only pancreatic cancer treated by Trifluridine-Tipiracil
|
Sarti, K.
|
|
|
214 |
C |
p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
214 |
C |
p.
|
artikel
|
| 7 |
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo
|
Reijers, Irene L.M.
|
|
|
214 |
C |
p.
|
artikel
|
| 8 |
Impact of the timing of immunotherapy administration on overall survival for resectable non-small cell lung cancer (iACORN study): A systematic review and meta-analysis of randomised trials
|
Patel, Akshay J.
|
|
|
214 |
C |
p.
|
artikel
|
| 9 |
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy – A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg
|
Kött, Julian
|
|
|
214 |
C |
p.
|
artikel
|
| 10 |
Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study
|
Trama, Annalisa
|
|
|
214 |
C |
p.
|
artikel
|
| 11 |
Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients
|
Robert, C.
|
|
|
214 |
C |
p.
|
artikel
|
| 12 |
Measuring quality in the care of metastatic colorectal cancer utilising available registry data: A modified Delphi study
|
Dunn, Catherine
|
|
|
214 |
C |
p.
|
artikel
|
| 13 |
Pancreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study
|
Radkiewicz, Cecilia
|
|
|
214 |
C |
p.
|
artikel
|
| 14 |
Patient access to perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel in patients with resectable gastric cancer in the Netherlands
|
Geerts, Julie F.M.
|
|
|
214 |
C |
p.
|
artikel
|
| 15 |
Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014)
|
Lugtenburg, Pieternella Johanna
|
|
|
214 |
C |
p.
|
artikel
|
| 16 |
Safety and efficacy of adjuvant FOLFOX/FOLFIRI with versus without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastasectomy (HARVEST trial): A randomized controlled trial
|
Wang, De-Shen
|
|
|
214 |
C |
p.
|
artikel
|
| 17 |
Sex differences in toxicities and survival outcomes among Japanese patients with Stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of 4 randomized controlled trials (JCOG2310A)
|
Hirano, Hidekazu
|
|
|
214 |
C |
p.
|
artikel
|
| 18 |
Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: Results from a three-stage collaborative study of large European prospective cohorts
|
Blandino, Alice
|
|
|
214 |
C |
p.
|
artikel
|
| 19 |
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors
|
Dimitriou, Florentia
|
|
|
214 |
C |
p.
|
artikel
|
Tijdschrift beschrijving